Shopping Cart
- Remove All
Your shopping cart is currently empty
Fradafiban binds to the human platelet GP IIb/IIIa complex with a Kd value of 148 nM. Fradafiban is a non-polypeptide platelet glycoprotein IIb/IIIa antagonist.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,820 | 10-14 weeks | |
| 50 mg | $2,380 | 10-14 weeks | |
| 100 mg | $3,100 | 10-14 weeks |
| Description | Fradafiban binds to the human platelet GP IIb/IIIa complex with a Kd value of 148 nM. Fradafiban is a non-polypeptide platelet glycoprotein IIb/IIIa antagonist. |
| Targets&IC50 | GP IIb/IIIa complex (human platelet):(kd)148 nM |
| In vitro | Fradafiban binds with high affinity and selectivity to the human platelet GP IIb/IIIa complex and potently inhibits human platelet aggregation in vitro.?Fradafiban reversibly binds to the human platelet GP IIb/IIIa complex with a Kd value of 148 nM.?Fradafiban is a nonpeptide mimetic of the arginine-glycine-aspartic acid recognition sequence. |
| In vivo | Fradafiban exhibits limited oral activity, likely attributed to its high polarity, which results in poor absorption following oral ingestion. |
| Synonyms | BIBU-52 |
| Molecular Weight | 367.40 |
| Formula | C20H21N3O4 |
| Cas No. | 148396-36-5 |
| Relative Density. | 1.38g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.